Metrion Biosciences, a specialist preclinical contract research organization (CRO) and a leader in ion channel screening, has appointed Lee Patterson as its new CEO, effective December 2, 2024.
 
An experienced life sciences and CRO executive, Patterson will guide the company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr. Andrew Southan, who has decided to step down as CEO after five years in the post.

Experience

Lee Patterson specializes in steering preclinical CROs to implement robust and effective plans for long-term commercial growth. Previously CEO at Charnwood Discovery, a provider of integrated drug discovery services with a global biotech and pharma client base, he led the company through its successful acquisition by Concept Life Sciences in October 2024. Before this, Patterson served as Chief Operating Officer at Quanticate, a global biometrics CRO, and Chief Operating Officer at Concept Life Sciences. He also held several executive roles at Covance/Labcorp, the most recent being Executive Director, Global Operations and Early Development Management Office.
 
Patterson will join recently appointed CCO Dr. Chris Mathes as the latest addition to Metrion’s senior leadership team. Working closely alongside Chris and the broader management team, Patterson’s C-suite level expertise and experience will help Metrion bolster its global commercial presence and scientific capabilities.
  
Keith McCullagh, Chairman of Metrion Biosciences, said, “I am delighted to welcome Lee Patterson to the Company. His experience of leading commercial CROs and his expertise in enhancing operational efficiencies are both outstanding and we look forward to working with him to continue Metrion’s growth as a specialist CRO serving global markets.”
 
Patterson remarked: “Metrion Biosciences has built an impressive reputation in ion channel drug discovery, with proven commitment to outstanding customer service and world-class science. I am excited to join this talented team and look forward to working with them to enhance and expand our specialized services to meet the needs of our clients worldwide.”